These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35240214)

  • 1. pH-sensitive hyaluronic acid-targeted prodrug micelles constructed via a one-step reaction for enhanced chemotherapy.
    Li M; Zhang L; Xuan Y; Zhi D; Wang W; Zhang W; Zhao Y; Zhang S; Zhang S
    Int J Biol Macromol; 2022 May; 206():489-500. PubMed ID: 35240214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH/reduction dual-responsive hyaluronic acid-podophyllotoxin prodrug micelles for tumor targeted delivery.
    Li M; Zhao Y; Sun J; Chen H; Liu Z; Lin K; Ma P; Zhang W; Zhen Y; Zhang S; Zhang S
    Carbohydr Polym; 2022 Jul; 288():119402. PubMed ID: 35450654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy.
    Li Y; Chen M; Yao B; Lu X; Zhang X; He P; Vasilatos SN; Ren X; Bian W; Yao C
    J Mater Chem B; 2019 Oct; 7(38):5814-5824. PubMed ID: 31495855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy.
    Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
    Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
    Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.
    Li C; Wang Y; Zhang S; Zhang J; Wang F; Sun Y; Huang L; Bian W
    Drug Deliv; 2021 Dec; 28(1):680-691. PubMed ID: 33818237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy.
    Lu B; Xiao F; Wang Z; Wang B; Pan Z; Zhao W; Zhu Z; Zhang J
    ACS Biomater Sci Eng; 2020 Jul; 6(7):4106-4115. PubMed ID: 33463311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-responsive hyaluronic acid-based prodrugs for efficient tumour targeting.
    Quagliariello V; Gennari A; Jain SA; Rosso F; Iaffaioli RV; Barbarisi A; Barbarisi M; Tirelli N
    Mater Sci Eng C Mater Biol Appl; 2021 Dec; 131():112475. PubMed ID: 34857264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
    Jiang Y; Zhou Y; Zhang CY; Fang T
    Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
    Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y
    Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin.
    Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D
    Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
    Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
    Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
    Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
    Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetal-linked polymeric prodrug micelles based on aliphatic polycarbonates for paclitaxel delivery: preparation, characterization,
    Zhou S; Fu S; Wang H; Deng Y; Zhou X; Sun W; Zhai Y
    J Biomater Sci Polym Ed; 2020 Oct; 31(15):2007-2023. PubMed ID: 32619161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tunable conjugation densities of camptothecin on hyaluronic acid for tumor targeting and reduction-triggered release.
    Chen Z; He N; Chen M; Zhao L; Li X
    Acta Biomater; 2016 Oct; 43():195-207. PubMed ID: 27424081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin delivered by redox-responsive Hyaluronic Acid-Ibuprofen prodrug micelles for treatment of metastatic breast cancer.
    Chai Z; Teng C; Yang L; Ren L; Yuan Z; Xu S; Cheng M; Wang Y; Yan Z; Qin C; Han X; Yin L
    Carbohydr Polym; 2020 Oct; 245():116527. PubMed ID: 32718631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents.
    Qu Y; Zhang C; Ma X; Gao Y; Liu J; Wu L
    Bioorg Med Chem; 2020 Dec; 28(24):115821. PubMed ID: 33091789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid prodrug micelles for tumour therapy.
    Sun J; Han L; Zhang S
    J Drug Target; 2022 Jan; 30(1):22-30. PubMed ID: 33913791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.